Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Apr;117(7):1481–1486. doi: 10.1111/j.1476-5381.1996.tb15310.x

Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.

N T Mudunkotuwa 1, R W Horton 1
PMCID: PMC1909451  PMID: 8730743

Abstract

1. The effects of repeated administration of the tricyclic antidepressant drug, desipramine (DMI), on behaviour (locomotor activity and rearing) and the number and affinity of brain beta-adrenoceptor and 5-HT2A receptor binding sites were examined in olfactory bulbectomized (OB) and sham-operated control rats. 2. Locomotor activity and rearing were increased in OB rats compared to sham-operated controls. The effect of various doses of DMI (administered orally twice daily for 21 days) on these behavioural measures was examined. A dose of 7.5 mg kg-1 provided optimal reversal of hyperlocomotion and increased rearing in OB rats, without changing these measures in sham-operated controls. 3. The time course of DMI (7.5 mg kg-1) on behavioural and neurochemical measures was examined. locomotion and rearing in OB rats were not significantly altered after 7 days, were significantly attenuated after 14 days and were normalized after 21 days. 4. After 7 days of DMI administration the number of beta-adrenoceptors was lower in frontal and occipital cortex and hippocampus. This reduction was largely restricted to the beta 1-adrenoceptor subtype. Administration of DMI for 14 or 21 days did not further reduce the number of beta-adrenoceptors. The DMI induced reduction in beta-adrenoceptors did not differ in OB and sham-operated control rats. 5. DMI administration for up to 21 days produced a progressive reduction in the number of 5-HT2A receptors in frontal cortex, without significant alterations in occipital cortex. 6. The time course of the reduction in the number of 5-HT2A receptors was similar to that of the DMI-induced behavioural changes whereas that for the reduction in beta-adrenoceptors was clearly different. 7. The present results suggest that the action of DMI in this animal model is unlikely to be directly related to a reduction in beta-adrenoceptors but may be related to a reduction in frontal cortical 5-HT2A receptors.

Full text

PDF
1481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arango V., Ernsberger P., Marzuk P. M., Chen J. S., Tierney H., Stanley M., Reis D. J., Mann J. J. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 1990 Nov;47(11):1038–1047. doi: 10.1001/archpsyc.1990.01810230054009. [DOI] [PubMed] [Google Scholar]
  2. Arora R. C., Meltzer H. Y. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 1989 Jun;146(6):730–736. doi: 10.1176/ajp.146.6.730. [DOI] [PubMed] [Google Scholar]
  3. Baker G. B., Greenshaw A. J. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol. 1989 Mar;9(1):1–44. doi: 10.1007/BF00711441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Banerjee S. P., Kung L. S., Riggi S. J., Chanda S. K. Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature. 1977 Aug 4;268(5619):455–456. doi: 10.1038/268455a0. [DOI] [PubMed] [Google Scholar]
  5. Bergstrom D. A., Kellar K. J. Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature. 1979 Mar 29;278(5703):464–466. doi: 10.1038/278464a0. [DOI] [PubMed] [Google Scholar]
  6. Cairncross K. D., Wren A., Forster C., Cox B., Schnieden H. The effect of psychoactive drugs on plasma corticosterone levels and behavioural in the bulbectomised rat. Pharmacol Biochem Behav. 1979 Mar;10(3):355–359. doi: 10.1016/0091-3057(79)90197-7. [DOI] [PubMed] [Google Scholar]
  7. Caldecott-Hazard S., Morgan D. G., DeLeon-Jones F., Overstreet D. H., Janowsky D. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse. 1991 Dec;9(4):251–301. doi: 10.1002/syn.890090404. [DOI] [PubMed] [Google Scholar]
  8. Cheetham S. C., Crompton M. R., Katona C. L., Horton R. W. Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res. 1988 Mar 8;443(1-2):272–280. doi: 10.1016/0006-8993(88)91621-6. [DOI] [PubMed] [Google Scholar]
  9. Cross J. A., Horton R. W. Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes. Br J Pharmacol. 1988 Feb;93(2):331–336. doi: 10.1111/j.1476-5381.1988.tb11438.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. De Paermentier F., Cheetham S. C., Crompton M. R., Horton R. W. Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177. Eur J Pharmacol. 1989 Aug 29;167(3):397–405. doi: 10.1016/0014-2999(89)90448-2. [DOI] [PubMed] [Google Scholar]
  11. Dooley D. J., Bittiger H. Quantitative assessment of central beta 1- and beta 2-adrenoceptor regulation using CGP 20712 A. J Pharmacol Methods. 1987 Sep;18(2):131–136. doi: 10.1016/0160-5402(87)90005-2. [DOI] [PubMed] [Google Scholar]
  12. Heal D. J., Butler S. A., Hurst E. M., Buckett W. R. Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex. J Neurochem. 1989 Oct;53(4):1019–1025. doi: 10.1111/j.1471-4159.1989.tb07389.x. [DOI] [PubMed] [Google Scholar]
  13. Hosoda K., Duman R. S. Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex. J Neurochem. 1993 Apr;60(4):1335–1343. doi: 10.1111/j.1471-4159.1993.tb03294.x. [DOI] [PubMed] [Google Scholar]
  14. Hrdina P. D., Demeter E., Vu T. B., Sótónyi P., Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993 Jun 18;614(1-2):37–44. doi: 10.1016/0006-8993(93)91015-k. [DOI] [PubMed] [Google Scholar]
  15. Hrdina P. D., Vu T. B. Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse. 1993 Aug;14(4):324–331. doi: 10.1002/syn.890140410. [DOI] [PubMed] [Google Scholar]
  16. Jesberger J. A., Richardson J. S. Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats. Behav Neurosci. 1986 Apr;100(2):256–274. doi: 10.1037//0735-7044.100.2.256. [DOI] [PubMed] [Google Scholar]
  17. Klimek V., Zak-Knapik J., Mackowiak M. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci. 1994 Jan;19(1):63–67. [PMC free article] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Leonard B. E., Tuite M. Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol. 1981;22:251–286. doi: 10.1016/s0074-7742(08)60295-0. [DOI] [PubMed] [Google Scholar]
  20. Lowther S., De Paermentier F., Crompton M. R., Katona C. L., Horton R. W. Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 1994 Apr 11;642(1-2):281–289. doi: 10.1016/0006-8993(94)90932-6. [DOI] [PubMed] [Google Scholar]
  21. Mann J. J., Stanley M., McBride P. A., McEwen B. S. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986 Oct;43(10):954–959. doi: 10.1001/archpsyc.1986.01800100048007. [DOI] [PubMed] [Google Scholar]
  22. Minneman K. P., Dibner M. D., Wolfe B. B., Molinoff P. B. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science. 1979 May 25;204(4395):866–868. doi: 10.1126/science.35829. [DOI] [PubMed] [Google Scholar]
  23. O'Connor W. T., Leonard B. E. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(1):41–51. doi: 10.1016/0278-5846(88)90060-7. [DOI] [PubMed] [Google Scholar]
  24. O'Connor W. T., Leonard B. E. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus. Neuropharmacology. 1986 Mar;25(3):267–270. doi: 10.1016/0028-3908(86)90250-9. [DOI] [PubMed] [Google Scholar]
  25. Riva M. A., Creese I. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol. Mol Pharmacol. 1989 Jul;36(1):201–210. [PubMed] [Google Scholar]
  26. Riva M. A., Creese I. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment. Mol Pharmacol. 1989 Jul;36(1):211–218. [PubMed] [Google Scholar]
  27. Sanders-Bush E., Breeding M., Knoth K., Tsutsumi M. Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system. Psychopharmacology (Berl) 1989;99(1):64–69. doi: 10.1007/BF00634454. [DOI] [PubMed] [Google Scholar]
  28. Stanley M., Mann J. J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1983 Jan 29;1(8318):214–216. doi: 10.1016/s0140-6736(83)92590-4. [DOI] [PubMed] [Google Scholar]
  29. Sugrue M. F. Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. Pharmacol Ther. 1983;21(1):1–33. doi: 10.1016/0163-7258(83)90065-7. [DOI] [PubMed] [Google Scholar]
  30. Wolfe B. B., Harden T. K., Sporn J. R., Molinoff P. B. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov;207(2):446–457. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES